HM
TEVA icon

Harvest Management’s Teva Pharmaceuticals TEVA Stock Holding History

Harvest Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,800
Closed -$571K – 92
2015
Q2 		$520K Buy
+8,800
New +$543K 0.37% 44

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Harvest Management's TEVA Position: Q3 2015 in Review

Harvest Management sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 8,800 shares — an estimated $571K sold.

Harvest Management first reported a position in TEVA in Q2 2015 and held it in 1 quarter. The position peaked at $520K in Q2 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

  • Harvest Management reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Harvest Management sold 8,800 Teva Pharmaceuticals shares in Q3 2015, an estimated $571K.
  • Harvest Management first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Harvest Management's Teva Pharmaceuticals position peaked at $520K in Q2 2015.
  • 823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Harvest Management's 13F filing for Q3 2015, filed 12 Nov 2015.